Stefan Zajic

Stefan Zajic

GlaxoSmithKline - Needham / United Kingdom
Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences
AD Scientific Index ID: 4371243
-
person_outline Stefan Zajic's MOST POPULAR ARTICLES
1-) Effect of the cathepsin K inhibitor odanacatib on bone resorption biomarkers in healthy postmenopausal women: two double‐blind, randomized, placebo‐controlled phase I studiesSA Stoch, S Zajic, J Stone, DL Miller, K Van Dyck, MJ Gutierrez, ...Clinical Pharmacology & Therapeutics 86 (2), 175-182, 20091802009
2-) Rifampin\'s acute inhibitory and chronic inductive drug interactions: experimental and model‐based approaches to drug–drug interaction trial designML Reitman, X Chu, X Cai, J Yabut, R Venkatasubramanian, S Zajic, ...Clinical Pharmacology & Therapeutics 89 (2), 234-242, 20111742011
3-) Theoretic criteria for antibody penetration into solid tumors and micrometastasesGM Thurber, SC Zajic, KD WittrupJournal of Nuclear Medicine 48 (6), 995-999, 20071722007
4-) Odanacatib, a selective cathepsin K inhibitor to treat osteoporosis: safety, tolerability, pharmacokinetics and pharmacodynamics–results from single oral dose studies in …SA Stoch, S Zajic, JA Stone, DL Miller, L Van Bortel, KC Lasseter, ...British journal of clinical pharmacology 75 (5), 1240-1254, 2013972013
5-) Influence of residual water on the adsorption of atmospheric gases in Li− X zeolite: experiment and simulationND Hutson, SC Zajic, RT YangIndustrial & Engineering Chemistry Research 39 (6), 1775-1780, 2000902000